insights_auto
Outlook: 61.1% bullish·5.6% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
US$ ११६.३३
arrow_downward
-०.६९%(-०.८१) 1D
अक्टोबर २, १२:०३:४० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
US$ ११६.७६
High
US$ ११७.१९
Low
US$ ११५.१७
Mkt. cap
२३.५८ अरब
Avg. vol.
१४.४७ लाख
Volume
५.१२ लाख
P/E ratio
१४.८२
52-wk high
US$ १३२.६०
52-wk low
US$ ८२.८२
EPS
US$ ७.८५
Beta
०.७४
Shares outstanding
२०.२७ करोड
No. of employees
३ हजार
Open
US$ ११६.७६
High
US$ ११७.१९
Low
US$ ११५.१७
Mkt. cap
२३.५८ अरब
Avg. vol.
१४.४७ लाख
Volume
५.१२ लाख
P/E ratio
१४.८२
52-wk high
US$ १३२.६०
52-wk low
US$ ८२.८२
EPS
US$ ७.८५
Beta
०.७४
Shares outstanding
२०.२७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Stock Traders Daily
·
७ घण्टा पहिले
Avoiding Lag: Real-Time Signals in (INCY) Movement
Benzinga
·
१८ घण्टा पहिले
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today
GuruFocus
·
१ दिन पहिले
INCY Maintained by Wells Fargo -- Price Target Raised to $128
AD HOC NEWS
·
१ दिन पहिले
Incyte presents EADV data for Incyte stock
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees२.८४ हजार
Founded२००२
HeadquartersWilmington, डेलावेयर, संयुक्त राज्य अमेरिका
Sector-
Websiteincyte.com